Abbasi, F., Brown, B. W., Lamendola, C. et al. Relationship between obesity, insulin resistance, and coronary heart disease risk. J. Am. Coll. Cardiol., 40:97–143, 2002.
Atkinson, M. A., and Eisenbarth, G. S. Type 1 diabetes: New per¬spectives on disease pathogenesis and treatment. Lancet, 358:221–29, 2001.
Brousseau, M. E., Schafer, E. J., and Wolfe, M. L. Effects of an inhibitor of cholesteryl ester transfer protein on HDL cholesterol. N. Engl. J. Med., 350:1505–1515, 2004.
Cho, E., Rimm, E. B., Srampfer, M. J. et al. The impact of diabetes mellitus and prior myocardial infarction on mortality from myocardial
infarction and from coronary heart disease in men. J. Am. Coll.
Cardiol., 40:954–60, 2002. Fajans, S. S., Bell, G. I., and Polonsky, K. S. Molecular mechanisms and
clinical pathophysiology of maturity onset diabetes of the young.
N. Engl. J. Med., 345:971–78, 2001. Gale, E. A. M. Can we change the course of beta cell destruction in
type 1 diabetes? N. Engl. J. Med., 346:1740–41, 2002. Marso, S. P. Optimizing in the diabetic formulary: Beyond aspirin and
insulin. J. Am. Coll. Cardiol., 40:652–61, 2002. Masoudi, F. A., Inzucchi, S. E., Wang, Y., Havranek, E. P., Foody, J. M.,
Krumholz, H. M. et al. Thiazolidinediones, Metformin, and outcomes

Страницы: 1 | 2 | 3